[Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients]

Pathol Biol (Paris). 1993 Apr;41(4):399-403.
[Article in French]

Abstract

The authors emphasize the interest of detecting HIV p24 antigen after immune complexes dissociation as well as changes in cellular viremia titers in the therapeutic follow-up of HIV infected patients. A significant decline of cell virus titers was found in 4-8 weeks among 13 of 20 zidovudine treated patients. A significant decrease of immune complexes dissociated p24 antigenemia was noted in 11 out of 17 patients.

Publication types

  • English Abstract

MeSH terms

  • Acquired Immunodeficiency Syndrome / blood*
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / immunology
  • Adult
  • Antigen-Antibody Complex / analysis
  • HIV Core Protein p24 / analysis*
  • HIV-1 / immunology
  • HIV-1 / isolation & purification*
  • Humans
  • Zidovudine / therapeutic use*

Substances

  • Antigen-Antibody Complex
  • HIV Core Protein p24
  • Zidovudine